MALAT1 and depressive symptom measurement: The MALAT1 levels did not show significance when comparing between the no TBI and rmTBI groups, but they were significantly different when comparing the groups with none to minimal–mild depression levels and when comparing the groups with minimal–mild to moderately severe–severe depression levels.